NEW YORK (GenomeWeb News) – Sequenom reported after the close of the market on Wednesday that its first-quarter revenues declined 18 percent year over year, while its net loss more than doubled on higher expenses.
Registering provides access to this and other free content.
Already have an account?Login Now.
David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.
In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.
Adam Rutherford discusses genetic genealogy at the Guardian.
Portions of the US 21st Century Cures Act are raising some safety concerns.